Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: A single institution result of 168 patients-Reference-Cited by-同舟云学术

Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lymphoma: A single institution result of 168 patients

Published:2008-01 Issue:4 Volume:49 Page:769-778
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Akhtar Saad,El Weshi Amr,Rahal Mohemmed,Khafaga Yasser,Tbakhi Abdelghani,Humaidan Hind,Maghfoor Irfan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190701843213

Reference30 articles.

1. Is There Any Difference in PBPC Mobilization Between Cyclophosphamide Plus G-CSF and G-CSF Alone in Patients with Non-Hodgkin's Lymphoma?

2. Harvesting of Autologous Blood Stem Cells after a Mobilising Regimen with Low-dose Cyclophosphamide

3. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate‐dose cyclophosphamide

4. Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Autologous stem cell transplantation in patients with primary refractory Diffuse Large B-cell lymphoma who demonstrate chemosensitivity to salvage chemotherapy;Clinical Hematology International;2024-04-10

2. Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study;Cancers;2023-01-18

3. Predictors of poor haematopoietic stem cell mobilisation in patients with haematological malignancies at a South African centre;Transfusion and Apheresis Science;2022-08

4. Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?;Journal of Clinical Apheresis;2020-12-17

5. Risk Factors for PoorAutologous Peripheral blood Stem Cell Mobilization among Lymphoproliferative Disease Patients;Bangladesh Journal of Medical Science;2020-03-10